Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Syllable

Explore full profile

Helps healthcare providers communicate with their patients using artificial intelligence

Mountain View, United StatesFounded 2016Health Tech & Medtech
Valuation $100–250M Last recorded · 2022
Revenue $10–50M Latest reported FY
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Syllable and the history behind them.

About Syllable

Syllable.ai is a cutting-edge startup focused on revolutionizing the healthcare industry through advanced artificial intelligence (AI) and machine learning (ML) technologies. The company operates primarily in the U.S. healthcare market, serving both patients and healthcare providers. Its core mission is to improve access to healthcare information and services by leveraging machine learning optimized for healthcare terminology and dialogue.

Syllable.ai offers an enterprise assistant designed to democratize access to information within healthcare organizations. This tool helps organizations improve operational efficiency by identifying areas for improvement and discovering new use cases in critical processes and workflows. By utilizing state-of-the-art natural language processing (NLP) and machine learning models, Syllable.ai generates valuable insights from text and voice data, aiding in better decision-making and patient care.

The company’s business model revolves around providing intelligent assistance to healthcare enterprises. It offers on-demand information about medical practices, diseases, and medications, making it easier for both patients and providers to access crucial healthcare information. Syllable.ai makes money through subscription-based services and enterprise solutions tailored to the needs of healthcare organizations.

One of the key benefits of Syllable.ai's technology is its ability to significantly reduce service costs. Healthcare organizations that have implemented Syllable.ai's machine learning processes report a reduction in service costs by over 50%. Additionally, more than 93% of these organizations agree that the machine learning tools provided by Syllable.ai have uncovered hidden or previously unobtained value.

In summary, Syllable.ai is at the forefront of integrating AI and ML into healthcare, offering solutions that enhance information access, operational efficiency, and patient insights.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2016
Headquarters
Mountain View, United States
Employees
54
Open positions
None listed
Dealroom signal
77.1/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Speech Recognition, Patient Engagement, Core AI
Technology
Artificial Intelligence, Deep Tech, Machine Learning, Nanotech, Natural Language Processing, Recognition Technology
Business model
SaaS
Client focus
b2b, b2c
Investment activity
1 company, latest Mar 2024
Capital deployed
—
Preferred round
ACQUISITION

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES COther financing Apr 2022 $40M $160M Oak HC/FT · Section 32 · TCV · Verily ↗
SERIES BOther financing Jun 2021 $28M $112M Oak HC/FT · Section 32 —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Syllable website traffic

Latest recorded traffic for Syllable is 9.2K monthly website visits, up 48.4% over the last three months. Syllable's team grew 1.9% over the past year.

Latest monthly visits9.2K 3-month web change+48.4% 1-year team growth+1.9%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed3 investors entered at this stage

Series A2 investors entered at this stage

Series B and later2 investors entered at this stage

Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇺🇸 United States90.6%
🇨🇱 Chile3.1%
🇹🇷 Turkey3.1%
🇧🇴 Bolivia3.1%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Syllable on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Syllable’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.